Assessment of Facial Symmetry After Facial Reconstruction Using Three-dimensional Stereophotogrammetry (SymFACE)

November 17, 2025 updated by: Assistance Publique Hopitaux De Marseille

Development, Validation and Clinical Application of a Method for Quantitative 3D Assessment of Facial Symmetry After Facial Reconstruction Using Three-dimensional Stereophotogrammetry

Facial reconstruction follows removal of a malignant or benign tumor of the oral cavity or face, complex facial trauma, or resection of osteonecrosis of the jaws. It's a challenge that aims to restore not only the functions of the face, but also its aesthetics, which is just as crucial. A poor aesthetic result after facial reconstruction has a serious impact on patient's lives. To develop more personalized surgery, and to anticipate and correct poor results in the future, it is essential to better understand the factors associated with poor aesthetic results in this type of surgery, as well as their impact on the patient's life.

This means correctly assessing the aesthetic outcome of this surgery. Today, however, aesthetic evaluation criteria remain inadequate. A number of criteria are involved in facial attractiveness, and facial symmetry is a key factor. It is generally accepted that severe facial asymmetries considerably diminish facial attractiveness. Currently, aesthetic evaluation criteria (particularly symmetry) are based primarily on the subjective perception of the surgeon or patient. However, there is a need to be able to measure facial symmetry objectively.

Methods for assessing symmetry rely on the placement of anatomical landmarks and the calculation of Euclidean distance, which involves locating homologous landmarks on each side of the face and comparing the length ratios of all possible lines connecting the landmarks on each side. However, these techniques are based on measurements often on two-dimensional (2D) photographs and do not take into account the three-dimensional nature of the face. Methods for three-dimensional analysis of facial symmetry have been developed based on three-dimensional CT reconstructions. However, this technique implies the use of an irradiating imaging technique, not systematically indicated at a distance from surgery.

This study aims to validate a method for analyzing facial symmetry using three-dimensional stereophotogrammetry, to identify risk factors for facial asymmetry in patients who have undergone facial reconstruction, and to assess the impact of facial asymmetry on patients' quality of life.

Study Overview

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Marseille, France, 13005
        • Recruiting
        • Assistance Publique - Hopitaux de Marseille
        • Contact:
        • Principal Investigator:
          • Nicolas GRAILLON, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent facial reconstruction, returning for consultation 1 year post-surgery.

Description

Inclusion Criteria:

  • Male or female, 18 years of age or older,
  • Patient having given non-opposition for participation in this study,
  • Reconstruction of the lower or middle third of the face by pedicled flap or microanastomosed free flap following excision of a benign or malignant tumor of the oral cavity or face, osteonecrosis of the jaws, loss of facial traumatic substance,
  • Surgery and routine follow-up performed in the 3 departments (maxillofacial surgery, ENT, plastic and reconstructive surgery) of the PROMOD cluster at Marseille's CHU Conception

Exclusion Criteria:

  • History of reconstruction of the lower or middle third of the face other than that being evaluated at one year for this study,
  • Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship, patients deprived of their liberty, pregnant or breast-feeding women),
  • Persons who cannot read and understand the French language well enough to be able to give their non-opposition to participating in the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Facial reconstruction patients
Reconstruction of the lower or middle third of the face using a pedicled flap or microanastomosed free flap following excision of a benign or malignant tumor of the oral cavity or face, osteonecrosis of the jaws, or traumatic loss of facial substance
Three stereoscopic photographs
  • SF-36 quality of life scale for general health inquiry
  • Rosenberg Self-Esteem Scale
  • Self-perception scale

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Correlation coefficient between root mean square deviation (RMSE) score and surgeon's assessment score
Time Frame: Day 1
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraclass Correlation Coefficient to assess intra-operator reproducibility
Time Frame: Day 1
Day 1
Intraclass Correlation Coefficient to assess inter-operator reproducibility
Time Frame: Day 1
Day 1
Demographic factors associated with objective facial asymmetry one year after facial reconstruction surgery
Time Frame: Day 1
Day 1
Clinical factors associated with objective facial asymmetry one year after facial reconstruction surgery
Time Frame: Day 1
Day 1
Therapeutic factors associated with objective facial asymmetry one year after facial reconstruction surgery
Time Frame: Day 1
Day 1
Relationship between objective measurement of facial asymmetry and the patient's subjective assessment of perception (satisfaction and body image)
Time Frame: Day 1
The patient perception score is assessed by a scale constructed by the investigative team.
Day 1
Relationship between objective measurement of facial asymmetry and the patient's quality of life
Time Frame: Day 1
The patient quality of life score is assessed by the French-validated SF-36 quality of life scale for general health inquiry" (36 items).
Day 1
Relationship between objective measurement of facial asymmetry and patient self-esteem
Time Frame: Day 1
The patient self-esteem score is assessed by the French-validated Rosenberg self-esteem scale (10 items).
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: CREMIEUX François, AP-HM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

July 30, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 2, 2024

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Facial Reconstruction

Clinical Trials on Three-dimensional stereophotogrammetry

Subscribe